07:00 , May 26, 2011 |  BC Innovations  |  Distillery Therapeutics

Indication: Cancer

This week in therapeutics Cancer Breast cancer CUE domain containing 2 (CUEDC2) In vitro studies suggest lowering CUEDC2 levels could help increase breast cancer response to hormonal therapy. In human breast cancer cell lines, CUEDC2...
07:00 , May 26, 2011 |  BC Innovations  |  Distillery Therapeutics

Indication: Autoimmune disease

This week in therapeutics Autoimmune disease Autoimmune disease CD28; inducible T cell co-stimulator ligand (ICOSLG; B7-H2) In vitro and cell culture studies suggest inhibiting interactions between B7-H2 and CD28 could help treat autoimmune disease. An...